Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 10 studies | 65% ± 27% | |
epithelial cell | 4 studies | 28% ± 11% | |
neuron | 3 studies | 40% ± 12% | |
goblet cell | 3 studies | 20% ± 4% | |
astrocyte | 3 studies | 32% ± 18% | |
oligodendrocyte | 3 studies | 26% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 36% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 98% | 2756.15 | 944 / 966 | 85% | 21.97 | 450 / 527 |
brain | 84% | 931.19 | 2214 / 2642 | 99% | 9.99 | 698 / 705 |
skin | 100% | 869.74 | 1804 / 1809 | 77% | 4.99 | 364 / 472 |
kidney | 96% | 599.75 | 85 / 89 | 81% | 8.54 | 728 / 901 |
prostate | 99% | 576.86 | 243 / 245 | 75% | 2.87 | 374 / 502 |
liver | 99% | 416.80 | 224 / 226 | 63% | 2.53 | 254 / 406 |
stomach | 83% | 221.92 | 297 / 359 | 73% | 18.81 | 209 / 286 |
esophagus | 90% | 271.80 | 1300 / 1445 | 58% | 3.12 | 106 / 183 |
bladder | 100% | 442.14 | 21 / 21 | 42% | 7.77 | 214 / 504 |
uterus | 100% | 573.86 | 170 / 170 | 38% | 2.83 | 176 / 459 |
adrenal gland | 100% | 1266.00 | 258 / 258 | 34% | 1.53 | 78 / 230 |
breast | 100% | 636.92 | 458 / 459 | 33% | 1.62 | 371 / 1118 |
pancreas | 98% | 463.38 | 321 / 328 | 30% | 1.17 | 53 / 178 |
lung | 85% | 249.83 | 493 / 578 | 41% | 1.84 | 476 / 1155 |
thymus | 100% | 493.23 | 651 / 653 | 7% | 0.33 | 43 / 605 |
ovary | 99% | 487.60 | 178 / 180 | 5% | 0.23 | 23 / 430 |
adipose | 100% | 595.93 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 686.45 | 1329 / 1335 | 0% | 0 | 0 / 0 |
muscle | 93% | 348.09 | 748 / 803 | 0% | 0 | 0 / 0 |
spleen | 86% | 203.12 | 207 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 39% | 1.19 | 31 / 80 |
heart | 32% | 65.09 | 272 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 16% | 0.52 | 7 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.08 | 1 / 29 |
peripheral blood | 1% | 2.61 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0048704 | Biological process | embryonic skeletal system morphogenesis |
GO_0001764 | Biological process | neuron migration |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0009880 | Biological process | embryonic pattern specification |
GO_0060021 | Biological process | roof of mouth development |
GO_0002076 | Biological process | osteoblast development |
GO_0051216 | Biological process | cartilage development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016363 | Cellular component | nuclear matrix |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003682 | Molecular function | chromatin binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | SATB2 |
Protein name | SATB homeobox 2 DNA-binding protein SATB2 (Special AT-rich sequence-binding protein 2) DNA-binding protein SATB (Special AT-rich sequence-binding protein) |
Synonyms | KIAA1034 |
Description | FUNCTION: Binds to DNA, at nuclear matrix- or scaffold-associated regions. Thought to recognize the sugar-phosphate structure of double-stranded DNA. Transcription factor controlling nuclear gene expression, by binding to matrix attachment regions (MARs) of DNA and inducing a local chromatin-loop remodeling. Acts as a docking site for several chromatin remodeling enzymes and also by recruiting corepressors (HDACs) or coactivators (HATs) directly to promoters and enhancers. Required for the initiation of the upper-layer neurons (UL1) specific genetic program and for the inactivation of deep-layer neurons (DL) and UL2 specific genes, probably by modulating BCL11B expression. Repressor of Ctip2 and regulatory determinant of corticocortical connections in the developing cerebral cortex. May play an important role in palate formation. Acts as a molecular node in a transcriptional network regulating skeletal development and osteoblast differentiation. . |
Accessions | ENST00000260926.9 [Q9UPW6-1] A0A8V8TPF3 ENST00000428695.6 [Q9UPW6-2] ENST00000700193.1 [Q9UPW6-1] ENST00000440919.1 ENST00000700191.1 [Q9UPW6-2] ENST00000700208.1 C9JR56 ENST00000417098.6 [Q9UPW6-1] F8WCV6 Q9UPW6 A0A8V8TR16 ENST00000700210.1 ENST00000457245.5 [Q9UPW6-1] ENST00000443023.5 |